Sunday, 25 Oct 2026

Empowering Chinese Pharma’s Global Expansion

Contact US
Insight,  China's Pharmaceutical Industry
  • Home
  • About US
  • Policy Hub
  • Categories
    • Drug
    • Company
    • Deals
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Legal / IP
    • Digital
  • Privacy Policy
  • Contact US
My News
  • Cancer
  • Clinical trial approval / initiation
  • Product approvals
  • Clinical trial results
  • Finance
  • ADC / XDC
  • Finanical Reports
  • Biotech
  • Market approval filings
  • PD-1/L1
Insight,  China's Pharmaceutical IndustryInsight,  China's Pharmaceutical Industry
  • Read History
Search
  • Pages
    • Home
    • Blog Index
    • POLICY HUB
    • Contact Us
  • Personalized
    • Read History
  • Categories
    • Company
    • Drug
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Digital
    • Legal / IP
    • Deals
Have an existing account? Sign In
Follow US
CompanyDeals

Ascletis Pharma and Roche Terminate Promotion Agreement for Pegasys

February 6, 2025
CompanyDeals

Apollomics Set to Merge with Maxpro Capital for Nasdaq Listing

February 6, 2025
Company

Everest Medicines Appoints Rogers Yongqing Luo as New CEO

February 6, 2025
DrugPolicy / Regulatory

Hainan’s Lecheng Zone Updates Special Drug Insurance List with Expanded Coverage

February 6, 2025
CompanyDeals

Shenzhen Vivolight Raises RMB 100 Million in Series D1 Financing for Laser Therapy Development

February 6, 2025
CompanyDigital

Best Covered Raises RMB 100 Million in Series A+ Funding for Cognitive Impairment Solution

February 6, 2025
CompanyDeals

US Blocks Asymchem’s Acquisition of Snapdragon Chemistry

February 6, 2025
CompanyDrug

Ascletis Completes Enrollment for HIV Functional Cure Study with PD-L1 Antibody ASC22

February 6, 2025
Policy / Regulatory

CDE Issues Guidelines for Anti-Tumor ADC Clinical Development

February 6, 2025
Company

Eli Lilly Announces Global C-Suite Changes, New Leadership in China

February 6, 2025
CompanyPolicy / Regulatory

China’s Policy Shifts Medical Device Procurement Toward Domestic Products

February 6, 2025
Company

Antengene Expands to Australia with New Melbourne Office

February 6, 2025
1 2 … 8 9 10 11 12 … 19 20
Insight,  China's Pharmaceutical Industry

Information You Can Trust: Stay instantly connected with breaking stories and live updates. From politics and technology to entertainment and beyond, we provide real-time coverage you can rely on, making us your dependable source for 24/7 news.

Youtube Medium Rss

About Company

  • Contact Us
  • Advertise with US
  • Complaint
  • Our Team
  • Our Values
  • Privacy Policy
Subscribe Now for Real-time Updates on the Latest Stories!

© 2026 Fineline Information & Technology. Independent intelligence on China’s pharmaceutical industry.  All Rights Reserved.

Fineline Information & Technology
Welcome to Fineline Cube!
Username or Email Address
Password

Lost your password?

Not a member? Sign Up